Answer to Simulation Analysis of Cost-Effectiveness in 2012 Has Finally Come in 2019

Affiliations

Comment

Shigeo Fuji. J Clin Oncol. 2020.

. 2020 Feb 10;38(5):522.

doi: 10.1200/JCO.19.02019. Epub 2019 Dec 5.

No abstract available

Comment in

Reply to S. Fuji.
Bachy E, Salles G. Bachy E, et al. J Clin Oncol. 2020 Feb 10;38(5):523. doi: 10.1200/JCO.19.02689. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804865 No abstract available.

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.
Bachy E, Seymour JF, Feugier P, Offner F, López-Guillermo A, Belada D, Xerri L, Catalano JV, Brice P, Lemonnier F, Martin A, Casasnovas O, Pedersen LM, Dorvaux V, Simpson D, Leppa S, Gabarre J, da Silva MG, Glaisner S, Ysebaert L, Vekhoff A, Intragumtornchai T, Le Gouill S, Lister A, Estell JA, Milone G, Sonet A, Farhi J, Zeuner H, Tilly H, Salles G. Bachy E, et al. J Clin Oncol. 2019 Nov 1;37(31):2815-2824. doi: 10.1200/JCO.19.01073. Epub 2019 Jul 24. J Clin Oncol. 2019. PMID: 31339826 Free PMC article. Clinical Trial.